Search - tctmd.com

Displaying 1 - 20 of 77

Sort: Relevancy | Date

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Todd Neale

December 28, 2022

News Daily News

Comparing TAVI Devices: Much Overlap, Some Nuances to Guide Care

Caitlin E. Cox

December 19, 2022

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Conference News PCR London Valves 2022

Registry Results See Less PVL, Pacemakers With Acurate neo2

Shelley Wood

November 29, 2022

News Conference News PCR London Valves 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

Shelley Wood

November 28, 2022

News Conference News PCR London Valves 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Another DOAC Fails in the Setting of Mechanical Heart Valves

Todd Neale

September 28, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Presentation TCT 2022

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

Presenter: Neil Fam

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

Advertisement

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Comparing TAVI Devices: Much Overlap, Some Nuances to Guide Care

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Registry Results See Less PVL, Pacemakers With Acurate neo2

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Another DOAC Fails in the Setting of Mechanical Heart Valves

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Ongoing Clinical Trials and the Future of LAAC

Recent Clinical Trials & Registries: Update 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content